גאלבוס 50 מ"ג

Χώρα: Ισραήλ

Γλώσσα: Εβραϊκά

Πηγή: Ministry of Health

Δραστική ουσία:

VILDAGLIPTIN 50 MG

Διαθέσιμο από:

NOVARTIS PHARMA SERVICES AG

Φαρμακολογική κατηγορία (ATC):

A10BH02

Φαρμακοτεχνική μορφή:

TABLETS

Οδός χορήγησης:

PER OS

Κατασκευάζεται από:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Θεραπευτική ομάδα:

VILDAGLIPTIN

Θεραπευτικές ενδείξεις:

Galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Ημερομηνία της άδειας:

2008-12-01